Vaxcyte, Inc.
- CIK: 0001649094
- EIN: 46-4233385
- Business address: 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, California, 94070
Information
Mailing address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, Delaware, 94070Phone
650-837-0111State location
CaliforniaState of incorporation
DelawareFiscal year end
December 31SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)Filings
N/A
About Vaxcyte, Inc.
Vaxcyte, Inc. (CIK: 0001649094) is an American company incorporated in the state of California. Head office is located at 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, California, 94070. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Vaxcyte, Inc. is a public company and trade via Over-The-Counter (OTC).Old names:
- SutroVax, Inc. from 2015-24-Jul to 2020-03-Apr
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Cowan Elvia | 0001960048 | Jan-01-2023 | officer: See Remarks Section |
| Eydelman Mikhail | 0001918033 | Apr-01-2022 | officer: SVP, Gen Counsel & Corp Sec |
| Kamarck Michael E. | 0001450730 | Oct-27-2021 | director |
| Paya Carlos V | 0001606244 | Oct-27-2021 | director |
| Dhaliwal Harpreet S. | 0001886794 | Oct-01-2021 | officer: SVP Cml Mfg & Supply Chain |
| Drapeau Anne S | 0001296569 | Sep-16-2021 | director |
| Loxam Teri | 0001829111 | Sep-16-2021 | director |
| Hopfner Robert Lorne | 0001551966 | Jan-06-2021 | director |
| RA Capital Healthcare Fund LP | 0001315082 | Jun-16-2020 | 10 percent owner |
| RA CAPITAL MANAGEMENT, L.P. | 0001346824 | Jun-16-2020 | 10 percent owner |
| Kolchinsky Peter | 0001384859 | Jun-16-2020 | 10 percent owner |
| Shah Rajeev M. | 0001619841 | Jun-16-2020 | 10 percent owner |
| BONDERMAN DAVID | 0000860866 | Jun-11-2020 | 10 percent owner |
| COULTER JAMES G | 0001099776 | Jun-11-2020 | 10 percent owner |
| GUGGENHIME ANDREW | 0001230724 | Jun-11-2020 | officer: CFO, CBO |
| EMSTER KURT VON | 0001252524 | Jun-11-2020 | director |
| ENRIGHT PATRICK G | 0001253886 | Jun-11-2020 | 10 percent owner |
| PICKERING GRANT | 0001258693 | Jun-11-2020 | director, officer: President & CEO |
| NEWELL WILLIAM J | 0001309660 | Jun-11-2020 | director |
| Heron Patrick J | 0001365617 | Jun-11-2020 | director |
| Abingworth LLP | 0001397144 | Jun-11-2020 | 10 percent owner |
| Tammenoms Bakker Juliet | 0001431159 | Jun-11-2020 | 10 percent owner |
| TPG Group Holdings (SBS) Advisors, Inc. | 0001495741 | Jun-11-2020 | 10 percent owner |
| Longitude Venture Partners II, L.P. | 0001527510 | Jun-11-2020 | 10 percent owner |
| Lukatch Heath | 0001596385 | Jun-11-2020 | director |
| Gilbert Halley E | 0001601360 | Jun-11-2020 | director |
| Mitchell Jane Wright | 0001614568 | Jun-11-2020 | officer: General Counsel |
| Longitude Capital Partners II, LLC | 0001647491 | Jun-11-2020 | 10 percent owner |
| Slaoui Moncef | 0001712369 | Jun-11-2020 | director |
| Hirth Peter | 0001813780 | Jun-11-2020 | director |
| Sauer Paul | 0001813796 | Jun-11-2020 | officer: SVP Process Dev, Manufacturing |
| Wassil Jim | 0001813798 | Jun-11-2020 | officer: Chief Operating Officer |
| Fairman Jeff | 0001813800 | Jun-11-2020 | officer: VP, Research |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vaxcyte, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SCHEDULE 13G/A | Document | Acc-no: 0000315066-25-000919 (34 Act) Size: KB | Feb-12-2025 | 25612624 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000012 ( Act) Size: 0 KB |
Feb-07-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000065 (33 Act) Size: 0 KB |
Feb-05-2025 | 25593152 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000010 ( Act) Size: 0 KB |
Feb-04-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000053 (33 Act) Size: 0 KB |
Feb-03-2025 | 25582504 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000008 ( Act) Size: 0 KB |
Jan-22-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000029 (33 Act) Size: 0 KB |
Jan-21-2025 | 25542508 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000006 ( Act) Size: 0 KB |
Jan-17-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000016 (33 Act) Size: 0 KB |
Jan-15-2025 | 25532928 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000004 ( Act) Size: 0 KB |
Jan-07-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000011 (33 Act) Size: 0 KB |
Jan-06-2025 | 25511002 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-25-000002 ( Act) Size: 0 KB |
Jan-03-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-25-000005 (33 Act) Size: 0 KB |
Jan-02-2025 | 25502123 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-24-000126 ( Act) Size: 0 KB |
Dec-19-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-24-000124 ( Act) Size: 0 KB |
Dec-18-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-24-000622 (33 Act) Size: 0 KB |
Dec-18-2024 | 241559160 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-24-000122 ( Act) Size: 0 KB |
Dec-10-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-24-000121 ( Act) Size: 0 KB |
Dec-10-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001649094-24-000118 ( Act) Size: 0 KB |
Dec-09-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001973141-24-000599 (33 Act) Size: 0 KB |
Dec-09-2024 | 241535151 |
Recent 20 filings. View all Vaxcyte, Inc. filings
Reviews
Pelisari
young lad who new his job ansered questions and new what was best for me.
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Catherine
Thanks I look forward to using the product to improve my skin tone
Frequently Asked Questions
Tags:
- Vaxcyte, Inc. overview
- Vaxcyte, Inc. job
- Vaxcyte, Inc. stock
- Vaxcyte, Inc. ownership
- Vaxcyte, Inc. CEO
- Vaxcyte, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 